Anna Chen - Profile and Investment Details

Investor Profile

Anna Chen is a Venture Capital, Private Equity Firm based in San Diego, California, United States with a diverse investment portfolio that includes companies such as Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics, Zavante Therapeutics, BlueWater Biosciences, Inc, Calistoga PharmaceuticalsChimerix, Alnara Pharmaceuticals, Nuon Therapeutics, Stemgent, Moximed, Incline Therapeutics, VentiRx Pharmaceuticals, Calibra Medical, Mirum Pharmaceuticals, Intradigm Corporation, Tarsus Pharmaceuticals, Alpine Immune Sciences, Aptinyx, Alcresta, Barosense, Silvergate Pharmaceuticals, Dascena, Cirius Therapeutics, Outpost Medicine, Rempex Pharmaceuticals, Aspen Neuroscience, Collegium Pharmaceutical, Seraxis, Calibrium, Mavupharma, Inipharm, Sierra Oncology, PatientKeeper, Kalidex Pharmaceuticals, AcertaPharma, Merganser Biotech, AnaptysBio, Sojournix, Iovance Biotherapeutics, Portola Pharmaceuticals, EBR Systems, Imago BioSciences, MBX Biosciences, Vaxcyte, Primaeva Medical, Alentis Therapeutics, Millendo Therapeutics, Clovis Oncology, Achaogen, Scout Bio, Cadence Pharmaceuticals, Passage Bio, Recida Therapeutics, Amunix, Phathom Pharmaceuticals, Lengo Therapeutics, Tobira Therapeutics, PowerVision, Calypso Medical, Cidara Therapeutics, Semnur Pharmaceuticals, CVRx, Gritstone Oncology, Glaukos, PreCision Dermatology, Threshold Pharmaceuticals, Eyconis, Inc, Iterum Therapeutics, Alteon Health, Arcutis Biotherapeutics, Entasis Therapeutics, Allena Pharmaceuticals, Laguna Pharmaceuticals, . Over time, Anna Chen has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Anna Chen is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Regenerative Medicine, Drug Discovery, Wellness, Women Founded, Film, Life Science, Engineering, Portfolio Management, Finance, Software, Biotechnology, Drug Development, Clinical Trials, Digital Health, Developer Tools, Medical, Information Technology, B2B, Therapeutics, Media and Entertainment, Machine Learning, Pharmaceuticals, Oncology may find it worthwhile to explore potential connections with Anna Chen, as their portfolio suggests a familiarity and interest in this area.

Understanding Anna Chen’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.